Loading...
•
Jun 30, 2023
Alkermes Q2 2023 Earnings Report
Alkermes demonstrated strong financial performance in Q2 2023, driven by proprietary product growth and the Janssen arbitration outcome.
Key Takeaways
Alkermes reported strong Q2 2023 financial results, with total revenues of $617.4 million, including $248.4 million from the Janssen arbitration. Net sales of proprietary products increased by 21% year-over-year. The company reiterated its financial expectations for the full year 2023.
Total revenues for the quarter were $617.4 million, compared to $276.2 million for the same period in the prior year.
Net sales of proprietary products increased approximately 21% year-over-year.
GAAP net income was $237.1 million, or $1.38 per diluted share.
The company recorded cash, cash equivalents and total investments of $907.2 million.
Alkermes
Alkermes
Alkermes Revenue by Segment
Revenue by Segment
VIVITROL Revenue
CapyFin.comARISTADA Revenue
CapyFin.comLYBALVI Revenue
CapyFin.com Forward Guidance
Alkermes reiterated its financial expectations for 2023.
Revenue & Expenses
Visualization of income flow from segment revenue to net income